Published 27 days ago • loading... • Updated 24 days ago

23andMe Special Committee Announces Exploration of Strategic Alternatives - 23andMe Holding (NASDAQ:ME)

23andMe is exploring strategic alternatives, including a possible sale or restructuring, as announced by its Special Committee on January 30, 2025.
The company's stock fell 10% after reporting an 82% loss in value last year, and its revenue dropped 8% to $39.6 million.
23andMe's worth has decreased significantly to under $100 million from a peak of $6 billion, prompting the need for additional liquidity.
Management expressed doubt about the company's ability to continue as a going concern, stating that there is no guarantee a deal will occur.

Insights by Ground AI

Does this summary seem wrong?

10 Articles

All

Left

Center

Right

Quartz

Reposted by

DNyuz

23andMe might sell itself as it runs out of money

23andMe (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic alternatives,” which could include a potential sale of the company or a restructuring.Read more...

25 days ago·United States

Read Full Article

CNBC

+2 Reposted by 2 other sources

23andMe is exploring strategic alternatives, looking to raise capital

23andMe said it's started exploring strategic alternatives, including a possible sale.

26 days ago·United States

Read Full Article

Seeking Alpha

23andMe says it's exploring alternatives, including a sale (ME:NASDAQ)

23andMe (ME) forms special board committee to explore strategic alternatives, including sale, restructuring, or business combination.

26 days ago·United States

Read Full Article

Benzinga

23andMe Special Committee Announces Exploration of Strategic Alternatives - 23andMe Holding (NASDAQ:ME)

SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (NASDAQ:ME) ("23andMe" or the "Company"), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, today announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a possible sale of the company, business com…

26 days ago·New York, United States

Read Full Article

bootsandsabers.com

23andMe Looking for Capital | Boots & Sabers

This is why sending my DNA off to one of these companies to satisfy a curiosity always seemed risky to me. What is this company’s #1 asset? The DNA it has collected from millions of people. While 23andMe may be an ethical company that protects your privacy, there is nothing preventing it from selling that asset to a predatory firm or a hostile foreign actor. Embattled genetic testing company 23andMe said on Tuesday that it’s started exploring str

25 days ago

Read Full Article

Busines and Oil News

23andMe is exploring strategic alternatives, looking to raise capital – DG Verifications & Stats

In this article ME Follow your favorite stocksCREATE FREE ACCOUNTAnne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023. Jordan Vonderhaar | Bloomberg | Getty Images Embattled genetic testing company 23andMe said on Tuesday that it’s started exploring strategic alternatives for a second time, which could include a sale of the company or…

25 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year